Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
Barden, M.,
Holzinger, A.,
Velas, L.,
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.,
Schütz, G.,
Hombach, A. A.,
Abken, H.:
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14, 1-13, (article identifier: 1110482), 2023.
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.:
CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.
Cancers (Basel). 15 (12), 3081-3097, (article identifier: 3081), 2023.
Mezősi-Csaplár, M.,
Szöllősi, J.,
Gottschalk, S.,
Vereb, G.,
Szöőr, Á.:
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, (article identifier: 4301), 2021.
